Disturbances in glucose and lipid metabolism, as well as insulin resistance, can downregulate the expression of endothelial NO synthase (eNOS) and the transport capacity of endothelial cell membranes for L-arginine, leading to a decrease in the production of NO by eNOS. This evidence concerns the gene NOS3 and Insulin resistance.